Hostname: page-component-74656f9884-npj9w Total loading time: 0 Render date: 2026-11-09T03:20:02.492Z Has data issue: false hasContentIssue false

Repair of the tricuspid valve in hypoplastic left heart syndrome

Published online by Cambridge University Press:  13 October 2006

Richard G. Ohye
Affiliation:
Division of Pediatric Cardiovascular Surgery, University of Michigan Medical School, Ann Arbor, Michigan, United States of America
Carlen A. Gomez
Affiliation:
Division of Pediatric Cardiology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America
Caren S. Goldberg
Affiliation:
Division of Pediatric Cardiology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America
Holly L. Graves
Affiliation:
Division of Pediatric Cardiovascular Surgery, University of Michigan Medical School, Ann Arbor, Michigan, United States of America
Eric J. Devaney
Affiliation:
Division of Pediatric Cardiovascular Surgery, University of Michigan Medical School, Ann Arbor, Michigan, United States of America
Edward L. Bove
Affiliation:
Division of Pediatric Cardiovascular Surgery, University of Michigan Medical School, Ann Arbor, Michigan, United States of America
Rights & Permissions [Opens in a new window]

Abstract

The outlook for patients with hypoplastic left heart syndrome has dramatically improved over the past two decades. Universally fatal only 25 years ago, since that time outcomes for staged palliation have shown consistent improvement. Recent reports show that eight to nine patients from every ten can now leave the hospital after the Norwood procedure.1 Attrition following the Norwood procedure, nonetheless, remains significant, with from five to fifteen percent of patients dying between the first and second stages of the Norwood sequence.1–4 Only three-quarters of the patients undergoing surgery for hypoplastic left heart syndrome survive after five years, even at the centres reporting the best outcomes for the Norwood procedure.1,5 In addition to the deaths, some patients are unable to progress through the three stages of reconstruction, and may require cardiac transplantation, or have no options for further therapy. There are many causes for these mortalities and morbidities following the Norwood procedure, including elevated pulmonary vascular resistance, cardiac arrhythmias, coronary arterial insufficiency, right ventricular failure, right ventricular volume overload due to shunt-dependent physiology, and tricuspid valvar regurgitation. Many of these factors are interrelated, and may form feedback loops, which serve to propagate their adverse effects on patients with hypoplastic left heart syndrome.

Figure 0

The technique for partial annuloplasty, which effectively obliterates the inferior leaflet of the tricuspid valve.

Figure 1

Comparison of patients achieving a successful as opposed to an adverse outcome, revealing a significant difference between partial annuloplasty alone and the need for any other repair technique or combination of techniques (p = 0.04). Abbreviation: TR: tricuspid regurgitation.

Figure 2

Comparison of pre-operative, early post-operative and late z values for the tricuspid valve between the patients achieving late success as opposed to those failing. Abbreviation: TR: tricuspid regurgitation.

Figure 3

Right ventricular function, as assessed on a scale of 4, with 4 being normal, 3 mildly depressed, 2 moderately depressed, and 1 severely depressed. The patients were segregated into groups, with Group A having early and late success, Group B having early failure but late success, Group C having early and late failure, and Group having early success but late failure. Abbreviations: RV: right ventricular; F/U: follow-up.